Which benzodiazepine is preferred for treating acute anxiety in a typical adult without significant comorbidities?

Best Benzodiazepine for Acute Anxiety

For acute anxiety in typical adults, lorazepam or diazepam are the preferred benzodiazepines, with the choice depending on whether you need episodic control (lorazepam) or sustained anxiety relief (diazepam).

Selection Based on Anxiety Pattern

The choice between benzodiazepines should be driven by the temporal pattern of anxiety symptoms 1:

• For episodic or situational anxiety: Use shorter-acting agents like lorazepam or oxazepam
• For sustained, chronic anxiety: Use longer-acting agents like diazepam or clorazepate

This distinction is critical because shorter-acting benzodiazepines provide rapid relief for discrete anxiety episodes, while longer-acting agents maintain more stable blood levels for continuous symptom control 1.

Evidence for Specific Agents

Lorazepam

Lorazepam has demonstrated efficacy in multiple clinical contexts and is widely recommended in guidelines. It appears in emergency department protocols for acute agitation 2 and has been used successfully in combination therapy. The drug has intermediate duration of action, making it versatile for both acute episodes and short-term management.

Diazepam

A 2025 network meta-analysis found no significant efficacy differences between individual benzodiazepines for generalized anxiety disorder, though diazepam showed slightly higher treatment discontinuation due to adverse effects (RR=1.61) 3. However, a 1984 comparative trial suggested diazepam may be more efficient than alprazolam in reducing anxiety and depressive symptoms, with better long-term efficacy at 4 weeks 4. Diazepam remains the drug of choice in UK guidelines for anxiety management 5.

Alprazolam

While alprazolam has been widely used (particularly in the US) for panic disorder and agoraphobia 6, UK guidelines specifically recommend against its use, especially for long-term treatment 5. Despite its popularity, there is no evidence it offers unique advantages over other benzodiazepines 6.

Critical Prescribing Parameters

Duration: Prescriptions should be limited to:

• Single doses or very short courses (1-7 days) for acute stress
• Short courses (2-4 weeks maximum) for severe anxiety 5
• The 2025 network meta-analysis confirmed all benzodiazepines are efficacious with favorable safety profiles 3

Dosing: Start with the lowest effective dose. For reference:

• Alprazolam: 0.25-0.5 mg orally 3 times daily (0.25 mg 2-3 times daily in elderly) 7, 8
• Lorazepam: Titrate based on response
• Diazepam: Average optimal dose ~15.8 mg daily in divided doses 4

Major Safety Concerns

Long-term Risks

A 2024 retrospective cohort study of 76,137 patients found that chronic benzodiazepine use (≥12 prescriptions) was associated with dramatically increased risks 9:

• Depressive disorders: HR 2.64
• Bipolar disorders: HR 4.39
• Substance use disorders: HR 3.00
• Alcohol use disorder: HR 3.38

This evidence strongly supports limiting benzodiazepine use to short-term treatment only.

Avoid Concurrent Use

Never prescribe benzodiazepines with opioids whenever possible—concurrent use quadruples overdose death risk 10. If unavoidable, check prescription drug monitoring programs and involve pharmacists in care coordination.

Special Populations

In elderly patients, benzodiazepines carry heightened risks of psychomotor impairment, falls, and paradoxical excitement 5. A 2025 geriatric emergency department review found midazolam particularly problematic in older adults, with excessive adverse events and higher redosing rates 11. Avoid midazolam in elderly patients; if benzodiazepines are necessary, use lower doses of lorazepam.

Clinical Algorithm

1. Assess anxiety pattern: Episodic vs. sustained
2. Choose agent:
   • Episodic → Lorazepam or oxazepam
   • Sustained → Diazepam
3. Start lowest effective dose
4. Limit duration: Maximum 2-4 weeks
5. Consider non-pharmacologic therapy: Cognitive behavioral therapy should be offered concurrently or as first-line when appropriate
6. Monitor closely: Reassess every few weeks initially
7. Taper gradually when discontinuing to avoid withdrawal seizures

Common Pitfalls

• Prescribing alprazolam long-term: Despite its popularity, there's no evidence of superiority and UK guidelines recommend against it 5
• Ignoring temporal patterns: Using long-acting agents for episodic anxiety or short-acting agents for sustained anxiety reduces efficacy 1
• Continuing beyond 4 weeks: The 2024 study found 44% of incident prescriptions exceeded recommended duration, contributing to dependence and subsequent psychiatric complications 12, 9
• Co-prescribing with opioids: This combination is particularly dangerous and should be avoided 10

Bottom line: While the 2025 network meta-analysis found no distinctive differences between benzodiazepines in efficacy 3, clinical practice favors lorazepam for episodic anxiety and diazepam for sustained anxiety, with strict limitation to short-term use given the substantial long-term psychiatric risks.